InnoGI Technologies.

InnoGI Technologies, formerly known as The TIM Company, is a Contract Research Organisation (CRO) that provides innovative services tailored to the Pharmaceutical Industry, specifically in the fields of gastrointestinal research and oral drug delivery. The company has developed the SurroGUT™ platform, which utilises advanced gastrointestinal technology to accurately mimic the dynamics of a real human gut. This cutting-edge technology is complemented by TIM systems, which offer up to 99% correlation with human formulation rankings, significantly enhancing predictive capabilities for clinical trials. Based in Delft, The Netherlands, InnoGI Technologies aims to minimise formulation iterations, reduce clinical risks, and accelerate time-to-market for its clients.

Services include:
- Contract Development and Manufacturing (CDMO)
- Contract Research
- Gastrointestinal Research Services
- Oral Drug Delivery Solutions

InnoGI Technologies is committed to providing exceptional support to the pharmaceutical sector, ensuring innovative solutions that meet the evolving needs of their clients. For more information, readers are encouraged to visit innogitechnologies.com.